IL137965A - Method for producing spherical pellets with a polymeric coating - Google Patents

Method for producing spherical pellets with a polymeric coating

Info

Publication number
IL137965A
IL137965A IL13796599A IL13796599A IL137965A IL 137965 A IL137965 A IL 137965A IL 13796599 A IL13796599 A IL 13796599A IL 13796599 A IL13796599 A IL 13796599A IL 137965 A IL137965 A IL 137965A
Authority
IL
Israel
Prior art keywords
grains
encased
polymer dispersion
prostane
polymeric coating
Prior art date
Application number
IL13796599A
Other languages
English (en)
Other versions
IL137965A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL137965A0 publication Critical patent/IL137965A0/xx
Publication of IL137965A publication Critical patent/IL137965A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Steroid Compounds (AREA)
IL13796599A 1998-02-24 1999-02-24 Method for producing spherical pellets with a polymeric coating IL137965A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19808634A DE19808634A1 (de) 1998-02-24 1998-02-24 Mantel für eine pharmazeutische Zusammensetzung
PCT/EP1999/001100 WO1999043303A1 (de) 1998-02-24 1999-02-24 Verfahren zur herstellung von ummantelten, sphärischen granulatkörnern

Publications (2)

Publication Number Publication Date
IL137965A0 IL137965A0 (en) 2001-10-31
IL137965A true IL137965A (en) 2005-11-20

Family

ID=7859315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13796599A IL137965A (en) 1998-02-24 1999-02-24 Method for producing spherical pellets with a polymeric coating

Country Status (18)

Country Link
US (1) US6723372B1 (xx)
EP (1) EP1058542B1 (xx)
JP (1) JP2002504506A (xx)
KR (1) KR100623542B1 (xx)
AT (1) ATE303133T1 (xx)
AU (1) AU753261B2 (xx)
CA (1) CA2321969C (xx)
CZ (1) CZ299252B6 (xx)
DE (2) DE19808634A1 (xx)
DK (1) DK1058542T3 (xx)
ES (1) ES2247786T3 (xx)
HU (1) HU226066B1 (xx)
IL (1) IL137965A (xx)
NO (1) NO20004225L (xx)
PL (1) PL193071B1 (xx)
RU (1) RU2209060C2 (xx)
SK (1) SK284062B6 (xx)
WO (1) WO1999043303A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19828881A1 (de) 1998-06-22 1999-12-23 Schering Ag Oxidationsinhibitor bei Prostan-Derivaten
US8323692B2 (en) * 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
ES2272914T3 (es) 2003-05-20 2007-05-01 Ethypharm Composicion farmaceutica oral de liberacion sostenida.
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
WO2007063946A1 (ja) 2005-11-30 2007-06-07 Fujifilm Ri Pharma Co., Ltd. アミロイドの凝集及び／又は沈着に起因する疾患の診断薬及び治療薬
RU2702690C2 (ru) * 2015-08-13 2019-10-09 БИОЛИНГУС АйПи ЛЛСи Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
CN106822013B (zh) * 2015-11-30 2020-05-12 北京泰德制药股份有限公司 前列环素类似物缓释制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA935093A (en) 1969-07-28 1973-10-09 Eurand S.R.L. Method of preparing granules with controlled release of the active substance contained therein
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
JPH10139659A (ja) 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤

Also Published As

Publication number Publication date
DK1058542T3 (da) 2006-01-02
AU2835299A (en) 1999-09-15
NO20004225D0 (no) 2000-08-23
US6723372B1 (en) 2004-04-20
PL193071B1 (pl) 2007-01-31
DE19808634A1 (de) 1999-08-26
CZ299252B6 (cs) 2008-05-28
SK284062B6 (sk) 2004-09-08
EP1058542A1 (de) 2000-12-13
NO20004225L (no) 2000-09-28
WO1999043303A1 (de) 1999-09-02
HU226066B1 (en) 2008-04-28
JP2002504506A (ja) 2002-02-12
ATE303133T1 (de) 2005-09-15
IL137965A0 (en) 2001-10-31
KR20010041210A (ko) 2001-05-15
CA2321969C (en) 2007-04-10
AU753261B2 (en) 2002-10-10
EP1058542B1 (de) 2005-08-31
ES2247786T3 (es) 2006-03-01
PL342315A1 (en) 2001-06-04
HUP0100752A2 (hu) 2001-08-28
CZ20003088A3 (cs) 2000-11-15
SK12422000A3 (sk) 2001-04-09
KR100623542B1 (ko) 2006-09-13
RU2209060C2 (ru) 2003-07-27
DE59912501D1 (de) 2005-10-06
CA2321969A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
US5595762A (en) Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications
DE69829655T3 (de) Biofunktionelle polymere im überkritischem fluid hergestellt
CA2281420A1 (en) Preparation of pharmaceutically-active granules
WO1997006787A3 (en) Controlled release products
Maganti et al. Compaction studies on pellets: II. Coated pellets
WO1995024929A3 (en) Polymeric gene delivery system
HK1010694A1 (en) microencapsulated 1,2-benzazoles.
CA2127352A1 (en) Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
CA2331785A1 (en) Process for microgel preparation
IL137965A0 (en) Method for producing spherical pellets with a polymeric coating
NZ335364A (en) Pellets having a core 250-355 um coated with an antifungal and a polymer, pharmaceutical, and process
AU2001277570A1 (en) Oral pharmaceutical composition with controlled release and prolonged absorption
RU92004344A (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, и способ их получения
ES2148300T3 (es) Microcapsulas para la liberacion controlada de acido acetilsalicilico.
US4702919A (en) Granules of thiamine salt and the production thereof
DE69929439D1 (de) Polyakrylsäure-granulate mit gesteuerter freigabe und verfahren zu dessen herstellung
CA2194610A1 (en) Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof
WO1990013994A3 (en) Controlled release of dihydrochalcones in chewing gum
DE3884214T2 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
DE3880919D1 (de) Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung.
WO1989011212A3 (en) Method of controlling release of cyclamate in chewing gum and gum produced thereby
JP2004522798A5 (xx)
CA2334385A1 (en) Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby
WO1990007864A3 (en) Method of controlling release of clycyrrhizin in chewing gum and gum produced thereby
CA2211778A1 (en) Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees